Meta-Analysis of Combined Therapy with Angiotensin Receptor Antagonists versus ACE Inhibitors Alone in Patients with Heart Failure | PLOS ONE
Differential Sex-Specific Effects of Angiotensin-Converting Enzyme Inhibition and Angiotensin Receptor Blocker Therapy on Arterial Function in Hypertension: CALIBREX Trial | Hypertension
FDA Advise-ERR: Concomitant use of Entresto and ACE inhibitors Can Lead to Serious Outcomes | Institute For Safe Medication Practices
COVID-19 and Use of Drugs Targeting the Renin-Angiotensin-System - American College of Cardiology
JCM | Free Full-Text | Angiotensin Converting Enzyme Inhibitors versus Receptor Blockers in Patients with Ventricular Tachyarrhythmias
Cross-Reactivity of ACE Inhibitor–Induced Angioedema with ARBs
Angiotensin-Converting Enzyme Inhibitors in Hypertension: To Use or Not to Use? - ScienceDirect
Interactions of coronaviruses with ACE2, angiotensin II, and RAS inhibitors—lessons from available evidence and insights into COVID-19 | Hypertension Research
Frontiers | Efficacy and Safety of Angiotensin-Converting Enzyme Inhibitor in Combination with Angiotensin-Receptor Blocker in Chronic Kidney Disease Based on Dose: A Systematic Review and Meta-Analysis
Angiotensin-Converting Enzyme Inhibitors in Hypertension: To Use or Not to Use? - ScienceDirect
Angiotensin-Converting Enzyme Inhibitors in Hypertension: To Use or Not to Use? | Journal of the American College of Cardiology
Prescription of renin–angiotensin system blockers and risk of acute kidney injury: a population-based cohort study | BMJ Open
Differences in the Clinical Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers: A Critical Review of the Evidence | American Journal of Cardiovascular Drugs
Comparative First-Line Effectiveness and Safety of ACE (Angiotensin-Converting Enzyme) Inhibitors and Angiotensin Receptor Blockers: A Multinational Cohort Study | Hypertension
Should Angiotensin-Converting Enzyme Inhibitors ever Be Used for the Management of Hypertension? | Current Cardiology Reports
Prioritization Tools— ACEI/ARB Case Study - Evaluating the Potential Use of Modeling and Value-of-Information Analysis for Future Research Prioritization Within the Evidence-Based Practice Center Program - NCBI Bookshelf
Prioritization Tools— ACEI/ARB Case Study - Evaluating the Potential Use of Modeling and Value-of-Information Analysis for Future Research Prioritization Within the Evidence-Based Practice Center Program - NCBI Bookshelf
A comparison between statin with ACE inhibitor or ARB therapy in STEMI patients who underwent successful PCI with drug-eluting stents - ScienceDirect
The similarities and differences of ACE inhibitors and ARBs (Uehara et... | Download Table
Should ACE-inhibitors and ARBs be stopped with COVID-19? — NephJC
Pharmacology ACE Inhibitors vs ARBs - Antihypertensive l Lisinopril, Losartan for NCLEX RN LPN - YouTube
From ACE Inhibitors/ARBs to ARNIs in Coronary Artery Disease and Heart Failure (Part 2/5) - ScienceDirect
RACGP - ACEIs for cardiovascular risk reduction – have we taken our eye off the ball?
ACE inhibitors, ARBs and direct renin inhibitors | Osmosis
